【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, February 2014 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, February 2014 14
2.2.1 Actavis to Acquire Forest Labs for US$25 Billion 14
2.2.2 Merck Enters into Licensing Agreement with Ablynx for Cancer Immunotherapy 15
2.2.3 Medtronic Completes Public Offering of Notes for US$2 Billion 15
2.2.4 Smith & Nephew Receives Regulatory Approval to Acquire ArthroCare for US$1.7 Billion 15
2.2.5 Mallinckrodt Completes Acquisition of Cadence Pharma for US$1.4 Billion in Tender Offer 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, February 2014 19
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, February 2014 20
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 21
3.1 Pharmaceuticals & Healthcare, Global, M&A, February 2014 21
3.1.1 Top M&A Deals in February 2014 22
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, September 2013 – February 2014 23
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, February 2014 25
3.2.1 Top Equity Offering Deals in February 2014 26
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, September 2013 – February 2014 27
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, February 2014 28
3.3.1 Top PE/VC Deals in February 2014 29
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, February 2014 30
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, February 2014 31
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, September 2013-February 2014 33
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, September 2013-February 2014 34
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, February 2014 35
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, February 2014 35
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, September 2013 – February 2014 37
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), February 2014 38
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, February 2014 39
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), September 2013 – February 2014 40
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, September 2013 – February 2014 42
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), September 2013 – February 2014 43
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), September 2013 – February 2014 45
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2014 47
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2014 47
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), February 2014 49
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, February 2014 50
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, February 2014 51
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, February 2014 51
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), September 2013 – February 2014 52
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), September 2013 – February 2014 54
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), September 2013 – February 2014 56
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), September 2013 – February 2014 58
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 60
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, February 2014 60
6.1.1 Oncology – Deals of the Month 61
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, February 2014 63
6.2.1 Central Nervous System – Deals of the Month 64
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, February 2014 66
6.3.1 Infectious Diseases – Deals of the Month 67
6.4 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, February 2014 69
6.4.1 Metabolic Disorders – Deal of the Month 70
6.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, February 2014 72
6.5.1 Immunology – Deal of the Month 73
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, February 2014 75
6.6.1 Cardiovascular – Deal of the Month 76
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, February 2014 77
6.7.1 Gastrointestinal – Deals of the Month 78
7 Deal Summary by Geography 80
7.1 Pharmaceuticals & Healthcare, North America Deals, February 2014 80
7.1.1 North America – Deals of the Month 81
7.2 Pharmaceuticals & Healthcare, Europe, Deals, February 2014 86
7.2.1 Europe – Deals of the Month 87
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, February 2014 89
7.3.1 Asia-Pacific – Deals of the Month 90
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, February 2014 92
7.4.1 Rest of the World – Deals of the Month 93
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 95
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, September 2013 – February 2014 95
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, September 2013 – February 2014 97
9 Further Information 99
9.1 Methodology 99
9.2 About GlobalData 100
9.3 Disclosure information 101
9.4 Disclaimer 101
【レポート販売概要】
■ タイトル：製薬業界における提携、ライセンシング、投資、M&A動向（2014年2月）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for February 2014 in Pharmaceuticals
■ 発行日：2014年3月31日
■ 調査会社：GlobalData
■ 商品コード：GDPH0450MD
■ 調査対象地域：グローバル
- 組織バンクの世界市場2016-2020About Tissue Banks Tissue banks are biorepositories for the preservation of human and animal tissues used for disease diagnosis, biodiversity studies, and research. These banks help in the storage of various types of tissue samples such as skin, bone, cornea, heart valves, umbilical cord, and human soft tissues. Tissue banks vary significantly in size, with tissue banks in medical institutions sto …
- 世界のIR検知器市場2015The Global IR Detector Industry 2015 Market Research Report is a professional and in-depth study on the current state of the IR Detector industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The IR Detector market analysis is provided for the international markets including development trends, competitive la …
- ロシアの石炭産業分析：Analyzing the Coal Industry in RussiaThe erstwhile Soviet Union which covered 1/8th of the entire world’s land mass had been a storehouse of Global Energy Sources in magnum quantities far beyond the capacity potentials of many Asian countries put together. Most of the high coal production basins of Russia had already been explored before the break up of the country into independent entities. The same is indicative of the fragmentatio …
- デジタルコンテンツの世界市場2019-2023133 Pages, November 2018 About this market Digital content service platforms are used by customers to obtain high-quality content. And it is becoming mandatory for digital content vendors to make the content meaningful, informative, and relevant. They also add various popular titles to the content libraries to boost the user experience and satisfaction levels. Technavio’s analysts have predicted t …
- 世界主要国における止血検査市場2015This 165-page report presents the clinical significance and market needs for major hemostasis laboratory tests, as well as extensive listings of companies developing or marketing innovative coagulation technologies and products. The report also includes strategic assessments of current and emerging suppliers of hemostasis diagnostic products, including marketing tactics, technological know-how, ne …
- 非在来型ガスの世界市場：シェールガス、タイトサンドガス、コールベッドメタン（CBM）About Unconventional Gas Unconventional gas is a type of natural gas resource trapped in coal beds, shale blocks, and tight sands. This gas resource is different from conventional sources in terms of reservoirs, geographical areas, and accumulation of natural gas. For the extraction of unconventional gas, different techniques are applied depending on the field and type of gas extracted. One common …
- 世界の農薬市場2014：主要企業の戦略的分析A strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, a task crucial to business survival, growth and profitability. Timely and factual competitive intelligence is vital to the success of all business functions, especially Planning, Marketing, R&D and Manufacturing.In a highly dynamic and fragmented agrochemical marke …
- クラウド式PLMの世界市場予測（～2021年）The Cloud Based PLM Market is expected to grow from USD 18.65 Billion in 2016 to USD 40.55 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 16.80% during the forecast period. Rising need for integrated PLM solution, effective management of supply chain, and increasing adoption of Internet of Things (IoT) are driving the cloud PLM market. The customer management is expected to grow at th …
- 世界の人工膵臓市場2015The Global Artificial Pancreas Industry Report 2015 is a professional and in-depth study on the current state of the Artificial Pancreas industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Artificial Pancreas market analysis is provided for the international markets including development trends, compet …
- Legacy Oil + Gas Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Legacy Oil + Gas Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Legacy Oil + Gas Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
- Inflammation：グローバル臨床試験レビューH2, 2013Inflammation Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Inflammation Global Clinical Trials Review, H2, 2013" provides data on the Inflammation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inflammation. It includes an overview of the trial numbers and their recruitment status as per the sit …
- Tension -Type Headache：グローバル臨床試験レビューH1, 2013Tension -Type Headache Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Tension -Type Headache Global Clinical Trials Review, H1, 2013" provides data on the Tension -Type Headache clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tension -Type Headache. It includes an overview of the trial numbers and …
- 住宅建築用塗料の世界市場2015-2019About residential architectural coatings Coatings are products used to protect a surface and/or enhance its appearance. Architectural coatings are applied to commercial and residential buildings. They serve to protect a building from elements such as moisture, UV radiation, and microbes. Paints, primers, lacquers, varnishes, and stains are some of the major types of architectural coating products. …
- 膵臓癌治療薬パイプライン分析“Pancreatic Cancer Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Pancreatic Cancer. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indica …
- バージンココナッツオイルの世界市場2017-2021About Virgin Coconut Oil Virgin coconut oil is different from normal coconut oil primarily in terms of the extraction process. Virgin coconut oil is extracted from coconut milk obtained from fresh coconut while normal coconut oil is extracted by cold compression with a moisture content of around 6%. The extraction of virgin coconut oil does not involve heat treatment. Virgin coconut oil tastes and …
